These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 20186975)

  • 1. Anxiety impairs depression remission in partial responders during extended treatment in late-life.
    Greenlee A; Karp JF; Dew MA; Houck P; Andreescu C; Reynolds CF
    Depress Anxiety; 2010 May; 27(5):451-6. PubMed ID: 20186975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treating depression to remission in older adults: a controlled evaluation of combined escitalopram with interpersonal psychotherapy versus escitalopram with depression care management.
    Reynolds CF; Dew MA; Martire LM; Miller MD; Cyranowski JM; Lenze E; Whyte EM; Mulsant BH; Pollock BG; Karp JF; Gildengers A; Szanto K; Dombrovski AY; Andreescu C; Butters MA; Morse JQ; Houck PR; Bensasi S; Mazumdar S; Stack JA; Frank E
    Int J Geriatr Psychiatry; 2010 Nov; 25(11):1134-41. PubMed ID: 20957693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Escitalopram is more effective than citalopram for the treatment of severe major depressive disorder].
    Azorin JM; Llorca PM; Despiegel N; Verpillat P
    Encephale; 2004; 30(2):158-66. PubMed ID: 15107719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors and moderators of time to remission of major depression with interpersonal psychotherapy and SSRI pharmacotherapy.
    Frank E; Cassano GB; Rucci P; Thompson WK; Kraemer HC; Fagiolini A; Maggi L; Kupfer DJ; Shear MK; Houck PR; Calugi S; Grochocinski VJ; Scocco P; Buttenfield J; Forgione RN
    Psychol Med; 2011 Jan; 41(1):151-62. PubMed ID: 20380782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What is the threshold for symptomatic response and remission for major depressive disorder, panic disorder, social anxiety disorder, and generalized anxiety disorder?
    Bandelow B; Baldwin DS; Dolberg OT; Andersen HF; Stein DJ
    J Clin Psychiatry; 2006 Sep; 67(9):1428-34. PubMed ID: 17017830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Escitalopram : a review of its use in the management of major depressive and anxiety disorders.
    Waugh J; Goa KL
    CNS Drugs; 2003; 17(5):343-62. PubMed ID: 12665392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Which symptoms predict recurrence of depression in women treated with maintenance interpersonal psychotherapy?
    Dombrovski AY; Cyranowski JM; Mulsant BH; Houck PR; Buysse DJ; Andreescu C; Thase ME; Mallinger AG; Frank E
    Depress Anxiety; 2008; 25(12):1060-6. PubMed ID: 18781665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice.
    Trivedi MH; Rush AJ; Wisniewski SR; Nierenberg AA; Warden D; Ritz L; Norquist G; Howland RH; Lebowitz B; McGrath PJ; Shores-Wilson K; Biggs MM; Balasubramani GK; Fava M;
    Am J Psychiatry; 2006 Jan; 163(1):28-40. PubMed ID: 16390886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence and predictors of relapse during continuation treatment of major depression with SSRI, interpersonal psychotherapy, or their combination.
    Rucci P; Frank E; Calugi S; Miniati M; Benvenuti A; Wallace M; Fagiolini A; Maggi L; Kupfer DJ; Cassano GB
    Depress Anxiety; 2011 Nov; 28(11):955-62. PubMed ID: 21898715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Difference in treatment outcome in outpatients with anxious versus nonanxious depression: a STAR*D report.
    Fava M; Rush AJ; Alpert JE; Balasubramani GK; Wisniewski SR; Carmin CN; Biggs MM; Zisook S; Leuchter A; Howland R; Warden D; Trivedi MH
    Am J Psychiatry; 2008 Mar; 165(3):342-51. PubMed ID: 18172020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Escitalopram for comorbid depression and anxiety in elderly patients: A 12-week, open-label, flexible-dose, pilot trial.
    Mohamed S; Osatuke K; Aslam M; Kasckow J
    Am J Geriatr Pharmacother; 2006 Sep; 4(3):201-9. PubMed ID: 17062320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Response and remission in depressive patients with anxiety symptoms treated with venlafaxine extended release in primary care].
    Roca Benassar M; Baca Baldomero E
    Actas Esp Psiquiatr; 2006; 34(3):162-8. PubMed ID: 16736389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment-emergent suicidal ideation during 4 months of acute management of unipolar major depression with SSRI pharmacotherapy or interpersonal psychotherapy in a randomized clinical trial.
    Rucci P; Frank E; Scocco P; Calugi S; Miniati M; Fagiolini A; Cassano GB
    Depress Anxiety; 2011 Apr; 28(4):303-9. PubMed ID: 21308882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) trial.
    Lespérance F; Frasure-Smith N; Koszycki D; Laliberté MA; van Zyl LT; Baker B; Swenson JR; Ghatavi K; Abramson BL; Dorian P; Guertin MC;
    JAMA; 2007 Jan; 297(4):367-79. PubMed ID: 17244833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medication augmentation after the failure of SSRIs for depression.
    Trivedi MH; Fava M; Wisniewski SR; Thase ME; Quitkin F; Warden D; Ritz L; Nierenberg AA; Lebowitz BD; Biggs MM; Luther JF; Shores-Wilson K; Rush AJ;
    N Engl J Med; 2006 Mar; 354(12):1243-52. PubMed ID: 16554526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Double-blind, randomized comparison of memantine and escitalopram for the treatment of major depressive disorder comorbid with alcohol dependence.
    Muhonen LH; Lönnqvist J; Juva K; Alho H
    J Clin Psychiatry; 2008 Mar; 69(3):392-9. PubMed ID: 18348597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bupropion extended release compared with escitalopram: effects on sexual functioning and antidepressant efficacy in 2 randomized, double-blind, placebo-controlled studies.
    Clayton AH; Croft HA; Horrigan JP; Wightman DS; Krishen A; Richard NE; Modell JG
    J Clin Psychiatry; 2006 May; 67(5):736-46. PubMed ID: 16841623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined therapy of major depression with concomitant borderline personality disorder: comparison of interpersonal and cognitive psychotherapy.
    Bellino S; Zizza M; Rinaldi C; Bogetto F
    Can J Psychiatry; 2007 Nov; 52(11):718-25. PubMed ID: 18399039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does the duration of index episode affect the treatment outcome of major depressive disorder? A STAR*D report.
    Gilmer WS; Gollan JK; Wisniewski SR; Howland RH; Trivedi MH; Miyahara S; Fleck J; Thase ME; Alpert JE; Nierenberg AA; Warden D; Fava M; Rush AJ
    J Clin Psychiatry; 2008 Aug; 69(8):1246-56. PubMed ID: 18681756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early symptom change prediction of remission in depression treatment.
    Katz MM; Meyers AL; Prakash A; Gaynor PJ; Houston JP
    Psychopharmacol Bull; 2009; 42(1):94-107. PubMed ID: 19204654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.